GRN and hepatocellular carcinoma: In nude mice model transplantedwith human HCC, dose-dependent inhibitory effect was demonstrated with theanti-GEP monoclonal antibodies, providing evidences that GEP is a therapeutictarget for HCC treatment [8].GEP expression has also been reported in a number of aggressive tumors, involvedin various biological processes including wound healing, murine fetal development,and mutation associated with frontotemporal lobar dementia [9].